Pharmacists in Bound Brook, New Jersey


13 Pharmacists found in Bound Brook
male pharmacist

Mr. Aaron Louis Weiss, RPH


Pharmacist
509 W Union Ave, Bound Brook, NJ 08805
732-469-0703     732-469-2833

male pharmacist

Anthony Paul Sclafani


Pharmacist
433 W Union Ave, Bound Brook, NJ 08805
732-356-3113     732-356-6691

female pharmacist

Bernadette Longo, RPH


Pharmacist
433 W Union Ave, Bound Brook, NJ 08805
732-356-3113    



female pharmacist

Mrs. Gail Rovinsky


Pharmacist
611 W Union Ave, Bound Brook, NJ 08805
732-302-9070     732-469-5159

male pharmacist

Jad Cocab


Pharmacist
476 W Union Ave, Bound Brook, NJ 08805
732-805-4014     732-805-4018

male pharmacist

Jatin K Patel, PHARMACIST


Pharmacist
433 W Union Ave, Bound Brook, NJ 08805
732-356-3113     732-356-6691

male pharmacist

Mr. Jeffrey A Voris, RPH


Pharmacist
476 W Union Ave, Bound Brook, NJ 08805
732-805-4014    

female pharmacist

Monica Paz


Pharmacist
476 W Union Ave, Bound Brook, NJ 08805
732-805-4014    

male pharmacist

Raja Veerabhadrudu Saridey


Pharmacist
52 Somerset Ct, Apt D, Bound Brook, NJ 08805
732-781-6733    

female pharmacist

Sachpreet Bajaj, PHARMD


Pharmacist
476 W Union Ave, Bound Brook, NJ 08805
732-805-4014    

male pharmacist

Mr. Steven Diaz, R.PH.


Pharmacist
303 E Main St, Bound Brook, NJ 08805
732-369-6081     732-369-6081

male pharmacist

Steven Moshinsky


Pharmacist
611 W Union Ave, Bound Brook, NJ 08805
732-302-9070     732-469-5159

male pharmacist

Mr. Tai D Truong


Pharmacist
476 W Union Ave, Bound Brook, NJ 08805
732-805-4014     732-805-4018


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.